Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial Receptivity After GnRH Agonist Triggering
NCT01500863Phase 4Completed
- Sponsor
- International Vaccine Institute
- Start
- Nov 2011
- Primary completion
- May 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triptorelin in ovarian hyperstimulation syndrome (OHSS), sponsored by International Vaccine Institute. Started Nov 2011; status: completed.
02
Drugs
triptorelin
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT01500863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500863.